Metropolis Healthcare, India’s second largest and most respected pathology laboratory chain, announced that it has been ...
The global Veterinary Reference Laboratory Market, valued at US$4.48 billion in 2024, stood at US$4.75 billion in 2025 and is ...
DELRAY BEACH, Fla., Nov. 25, 2025 /PRNewswire/ -- The global Veterinary Reference Laboratory Market, valued at US$4.48 billion in 2024, stood at US$4.75 billion in 2025 and is projected to advance at ...
News Medical on MSN
New molecular test revolutionizes fungal infection diagnosis
Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil exposure. These infections can affect both healthy and immunocompromised ...
Researchers at The University of Texas MD Anderson Cancer Center have identified a specific protein, RASH3D19, that is ...
News-Medical.Net on MSN
Novel antibody suppresses primary tumor growth and spread of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is one of the most aggressive and treatment-resistant forms of breast cancer. It grows ...
Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced today that it has welcomed Dr. Josh ...
It's not often that a pathologist gets to make a diagnosis that works for the patient by preventing treatment from occurring.
The anonymous gift is estimated to exceed $50 million over the next 50 years to UW's Department of Laboratory Medicine and ...
Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.
A new article reflects on how two generations of scientists reshaped thinking on aging, linking hormonal regulation in the brain to molecular growth pathways. Mikhail Blagosklonny spent his career ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results